At the same time, the company is appreciated on the European forum
Microsoft, PZU Group and uPacjenta.pl as the newest partners of the company
Startups of the third and fourth rounds are getting ready
Cardiomatics develops its technology in response to the increasing demand
The researchers managed to achieve almost two years of disease remission after administration of the Treg preparation
The company's response to Covid-19
NNOventure invests in RevDeBug
New product lines and services
We finance the development of medical technology for the treatment of Alzheimer's disease
Increased demand is a challenge for e-grocery companies
Technology facilitating the fight against the spread of CoViD-19
Artificial intelligence will improve the handling of insurance claims
